CompletedNot Applicable

Measuring the Impact of MANNA s Medically Tailored Meal Program in Patients With a Non-terminal Cancer Diagnosis

United States46 participantsStarted 2021-08-11

Plain-language summary

This study identifies patient-important outcome measures and develops a survey that assesses the impact of nutritional interventions among cancer patients. Currently, data on the impact of medically tailored meals on outcomes that are meaningful to patients, providers, and payers are limited. For this reason, access to medically tailored meals as a covered benefit for cancer patients is limited. Thus, there is a need to explore the efficacy of nutritional interventions among this population. This study identifies outcome measures for nutritional interventions that are meaningful to patients and providers.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * AIM 1 PATIENTS: SKCC oncology patients * AIM 1 PATIENTS: Currently receiving cancer treatment * AIM 1 PATIENTS: 18 years or older * AIM 1 PATIENTS: English speaking \* Pending funding and staff abilities, efforts will be made to include other languages if possible * AIM 1 PATIENTS: 10 patients have received MANNA services in past 6 months * AIM 1 PATIENTS: 10 patients currently receiving cancer treatment for curative intent, screen positive for nutrition risk, and report food insecurity \* Nutrition risk = a score of \>= 2 on the Malnutrition Screening Tool, weight loss of 5% over 1 months, or weight loss of \> 10% over 6 months * AIM 1 PATIENTS: 10 patients currently receiving cancer treatment for curative intent, screen positive for nutrition risk, and do not report food insecurity * AIM 1 CLINICIANS: Providing care/support for oncology patients * AIM 1 CLINICIANS: English speaking * AIM 2 PATIENTS: Current SKCC oncology patient * AIM 2 PATIENTS: 18 years or older * AIM 2 PATIENTS: English speaking * Pending funding and staff abilities, efforts will be made to include other languages if possible * AIM 2 PATIENTS: 3-5 patients have received MANNA services in past 6 months * AIM 2 PATIENTS: 3-5 patients currently receiving cancer treatment for curative intent, screen positive for nutrition risk, and report food insecurity \* Nutrition risk = a score of \>= 2 on the Malnutrition Screening Tool, weight loss \> 5% over 1 month, or weight loss o…

What they're measuring

identify patient-important outcomes related to receiving nutrition services by engaging patients with cancer and clinicians

Timeframe: At study completion; approximately 60 minutes

Usability

Timeframe: At study completion; approximately 60 minutes

Feasibility

Timeframe: At study completion; approximately 60 minutes

Trial details

NCT IDNCT05118802

SponsorThomas Jefferson University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-03-03

View on ClinicalTrials.gov More Hematopoietic and Lymphoid Cell Neoplasm trials

Plain-language summary

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

identify patient-important outcomes related to receiving nutrition services by engaging patients with cancer and clinicians

Timeframe: At study completion; approximately 60 minutes

Usability

Timeframe: At study completion; approximately 60 minutes

Feasibility

Timeframe: At study completion; approximately 60 minutes